C
ISSUER//CIK 0001337223
CytRx Oncology Corp
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A162.8 KBCytRx Oncology CorpFeb 17, 3:14 PM ET·0001144204-09-008869
- 10-K/A210.8 KBInnovive Pharmaceuticals, Inc.Apr 29, 3:45 PM ET·0000950123-08-004833
- 48.9 KBInnovive Pharmaceuticals, Inc.Jul 12, 4:47 PM ET·0001181431-07-045404
- 49.5 KBInnovive Pharmaceuticals, Inc.Jul 12, 4:46 PM ET·0001181431-07-045403
- 8-K1.3 MBInnovive Pharmaceuticals, Inc.Jun 29, 5:23 PM ET·0000950144-07-006247
- SC 13G83.9 KBInnovive Pharmaceuticals, Inc.Jun 13, 11:06 AM ET·0000950135-07-003633
- 8-K25.4 KBInnovive Pharmaceuticals, Inc.Jun 7, 3:42 PM ET·0000950123-07-008408
- 8-K26.2 KBInnovive Pharmaceuticals, Inc.Jun 4, 4:35 PM ET·0000950144-07-005451
- 8-K13.1 KBInnovive Pharmaceuticals, Inc.May 11, 1:48 PM ET·0000950123-07-007280
- 8-K281.3 KBInnovive Pharmaceuticals, Inc.Apr 25, 1:42 PM ET·0000950123-07-005965
Insiders
9Tickers
No tickers on record
Addresses
business
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
mailing
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
Former Names
- Innovive Pharmaceuticals, Inc.2008-08-14